Understand the source comparison
Cyclical vs Linear Peptides: Structural and Functional Comparison
Backbone structure Open chain with free N- and C-termini Closed ring via head-to-tail peptide bond or side-chain bridge Cyclical structure eliminates exopeptidase cleavage sites. The single most impactful difference for in vivo stability Enzymatic stability Su
No winner is assigned.
This page preserves a source comparison for education. It does not add a rating, recommendation or clinical judgment.
- Backbone structure
- Open chain with free N- and C-termini
- Closed ring via head-to-tail peptide bond or side-chain bridge
- Cyclical structure eliminates exopeptidase cleavage sites. The single most impactful difference for in vivo stability
- Enzymatic stability
- Susceptible to exopeptidases and endopeptidases; half-life 5–30 min in plasma
- Resistant to exopeptidases; half-life 4–12 hours in plasma
- 10–50× stability increase is consistent across species. Not compound-specific
- Conformational flexibility
- High entropy; multiple low-energy conformations in solution
- Constrained geometry; single predominant conformation
- Flexibility is a liability for receptor selectivity. Cyclisation trades plasticity for precision
- Oral bioavailability
- <2% due to gastric and intestinal degradation
- 10–30% depending on molecular weight and lipophilicity
- Linear peptides cannot survive oral administration. Cyclical structures are the only viable peptide option for oral delivery
- Receptor binding affinity
- Lower due to entropic penalty during conformational reorganisation
- Higher due to preorganised bioactive conformation
- 5–20× affinity increase is common. Cyclisation reduces entropy cost of binding
- Synthesis complexity
- Standard solid-phase peptide synthesis (SPPS)
- Requires cyclisation step post-synthesis; yield 40–70%
- Linear synthesis is simpler and cheaper, but cyclical peptides justify the cost in applications requiring stability